Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omicron – The new SARS‐CoV‐2 challenge?
Alexandra Lino, Marita A. Cardoso, Paula Martins‐Lopes, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 4
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness
Wenhao Liu, Zehong Huang, Jin Xiao, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 184-184
Open Access | Times Cited: 20
Characterization of SARS-CoV-2 recombinants and emerging Omicron sublineages
Yuliang Wang, Yiyin Long, Feng Wang, et al.
International Journal of Medical Sciences (2023) Vol. 20, Iss. 1, pp. 151-162
Open Access | Times Cited: 23
Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study
Sara Y. Tartof, Jeff Slezak, Laura Puzniak, et al.
The Lancet Respiratory Medicine (2022) Vol. 11, Iss. 2, pp. 176-187
Open Access | Times Cited: 28
Antibody responses in Omicron BF.7-infected patients vaccinated with inactivated SARS-CoV-2
Yabo Zhao, Weili Li, Liming Xu, et al.
Virology (2025) Vol. 603, pp. 110404-110404
Closed Access
SARS-CoV-2 Variants: Genetic Insights, Epidemiological Tracking, and Implications for Vaccine Strategies
Fatimah S. Alhamlan, Ahmed A. Al‐Qahtani
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1263-1263
Open Access
The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2
Letian Fang, Jie Xu, Yue Zhao, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 13
Platelet-derived extracellular vesicles for drug delivery
Chenlu Yao, Chao Wang
Biomaterials Science (2023) Vol. 11, Iss. 17, pp. 5758-5768
Closed Access | Times Cited: 12
Potential of green tea EGCG in neutralizing SARS-CoV-2 Omicron variant with greater tropism toward the upper respiratory tract
Zhichao Zhang, Meng Hao, Xiangchun Zhang, et al.
Trends in Food Science & Technology (2022) Vol. 132, pp. 40-53
Open Access | Times Cited: 20
Emerging trends in point-of-care biosensing strategies for molecular architectures and antibodies of SARS-CoV-2
Gopi Karuppaiah, Arti Vashist, Madhavan Nair, et al.
Biosensors and Bioelectronics X (2023) Vol. 13, pp. 100324-100324
Open Access | Times Cited: 11
Viral target and metabolism‐based rationale for combined use of recently authorized small molecule COVID‐19 medicines: Molnupiravir, nirmatrelvir, and remdesivir
Daisy Yan, Bingfang Yan
Fundamental and Clinical Pharmacology (2023) Vol. 37, Iss. 4, pp. 726-738
Open Access | Times Cited: 10
SARS‐CoV‐2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID‐19 vaccine: Looking for correlates of protection
Ignacio Torres, Estela Giménez, Eliseo Albert, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4216-4223
Open Access | Times Cited: 17
Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus from November 2020 to October 2021: The Passage of Waves of Alpha and Delta Variants of Concern
Andreas C. Chrysostomou, Bram Vrancken, Christos Haralambous, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 108-108
Open Access | Times Cited: 15
Suramin inhibits SARS-CoV-2 nucleocapsid phosphoprotein genome packaging function
Irene Boniardi, Angela Corona, J. Basquin, et al.
Virus Research (2023) Vol. 336, pp. 199221-199221
Open Access | Times Cited: 8
Emergence of SARS‐CoV‐2 Omicron variant and strategies for tackling the infection
Yan Wu, Yiyin Long, Feng Wang, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 12
Open Access | Times Cited: 13
A DNA biosensors-based microfluidic platform for attomolar real-time detection of unamplified SARS-CoV-2 virus
Perrine Robin, Laura Barnabei, Stefano Marocco, et al.
Biosensors and Bioelectronics X (2022) Vol. 13, pp. 100302-100302
Open Access | Times Cited: 9
Emergence of New SARS-CoV2 Omicron Variants after the Change of Surveillance and Control Strategy
José María González Alba, Zulema Pérez-Martínez, José Antonio Boga, et al.
Microorganisms (2022) Vol. 10, Iss. 10, pp. 1954-1954
Open Access | Times Cited: 8
Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection
Zhen Xu, Yunting Zou, Xi Gao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
SARS-CoV2 mutations and impact on mortality: observational study in a sub-saharan Africa hospital
J.R. Makulo, Roger Wumba, Madone Mandina, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Characteristics of the severe acute respiratory syndrome coronavirus 2 omicron BA.2 subvariant in Jilin, China from March to May 2022
Han Liu, Shuai Wang, Siqi Yang, et al.
Journal of Translational Internal Medicine (2022) Vol. 10, Iss. 4, pp. 349-358
Open Access | Times Cited: 5
A novel, ultrafast, ultrasensitive diagnosis platform for the detection of SARS‐COV‐2 using restriction endonuclease‐mediated reverse transcription multiple cross displacement amplification
Junfei Huang, Xinggui Yang, Lijuan Ren, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 2
Open Access | Times Cited: 5
Fatal cases after Omicron BA.1 and BA.2 infection: Results of an autopsy study
Bruno Märkl, Sebastian Dintner, Tina Schaller, et al.
International Journal of Infectious Diseases (2022) Vol. 128, pp. 51-57
Open Access | Times Cited: 5
Future Frontiers: A Tale of Three Cities and the World
Li Sheng
Sustainable development goals series (2024), pp. 89-102
Closed Access
Exploration of the link between COVID-19 and gastric cancer from the perspective of bioinformatics and systems biology
Xiao Ma, Tengda Huang, Xiaoquan Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Current Progress in Genomic and Genetic Research on Human Viral Diseases
Binhua Liang, Birte Möhlendick, Hezhao Ji, et al.
Frontiers research topics (2024)
Open Access
Page 1 - Next Page

Scroll to top